Report on cardiovascular health and diseases in China 2024:Epidemiological status of cardiovascular diseases and their risk factorsThe Writing Committee of the Report on Cardiovascular Health and Diseases in China 2024, WANG Zeng-wu771-793
Report on cardiovascular health and diseases in China 2024:Diagnosis and Treatment Status of Arrhythmia and Heart FailureThe Writing Committee of the Report on Cardiovascular Health and Diseases in China 2024, WANG Zeng-wu794-803
Predictive value of the age-adjusted charlson comorbidity index for cardiogenic death in patients with heart failure with reduced ejection fractionZHAO Chun-xiu, ZHANG Xue-he, SUN Hua-xin, WANG Zhong, WANG Han-xiao, KANG Sheng-nan, ZHANG Tong, ZHANG Chuan804-810
Study on machine learning-based mortality prediction models for hypertensive heart failureWANG Miao, FAN Hong-xuan, WANG Lei-gang, REN Zhao-yu, LIANG Bin811-818
Construction of prediction model and risk stratification for heart failure complications in acute myocardial infarction patients based on big medical test dataCAO Wei, YANG Zhi-ning, JI Bing, WANG Li-juan819-824
Expression and significance of serum CXC chemokine ligand 12,poly ADP-ribose polymerase 1 and Kruppel-like factor 15 in patients with chronic heart failurePENG Qing, XIAO Yao, NI Li-ting825-830
Abnormal expression of serum biomarkers in assessing cardiac function and prognosis in heart failure patients complicated with pulmonary infectionBAI Xian-ying, LI Ke-fan, LIU Xiang-qin, XUE Yun, ZHANG Jing-mei831-835
Progress in the treatment of heart failure after myocardial infarctionWANG Xiao, WANG Jing-yao, YANG Yan-li, LEI Meng-jie, LI Ya-chao, LI Cai-rong, ZHAO Zhi-gang, XUE Zeng-ming836-842
Insulin resistance in heart failure with preserved ejection fraction:Mechanisms and advances in metabolic-targeted therapiesYANG Niao, MEI Chao-sheng, MIN Xuan, QIN Cui-min843-848
Advances in the use and study of fenelidone in the treatment of heart failureZHOU Yu-fei, ZHANG Ya-hao, JIANG Shu-bin849-854
